The European Fight Over CBD Continues {$excerpt:n} Analogies between the patterns and paths that cannabis legalization is taking—between Canada and Europe, and more recently, the U.S. and Europe—are certainly in the room this year. Especially as different European states begin to at least engage if not normalize parts of the cannabis discussion—from medical and…

Panaxia becomes first in Europe to be approved to export cannabis solution {$excerpt:n} Israeli medical cannabis giant Panaxia announced in a press release on Wednesday that they have become the first company to receive regulatory approval to market an inhalable cannabis solution in Europe – Germany, more specifically – along with their strategic partner, the German pharmaceutical…

The Medical Cannabis Conundrum In Europe {$excerpt:n} Alfredo Pascual: Hello, and welcome everyone. My name is Alfredo Pascual; I am vice president of investment analysis at fast forward innovations. And today, I will be moderating this panel with Tjalling Erkelens, CEO of BEDROCAN, and Alex Agius Saliba, member of the European parliament. And let’s start…

As travel restrictions ease, this European city wants to ban cannabis tourism {$excerpt:n} As more and more people get vaccinated, travel climbs higher onto people’s priority lists. And for cannabis consumers, there’s one particular European destination that likely tops the list. On Wednesday, the European Union announced that they would be reopening their borders to vaccinated…

The European Union Is Quickly Becoming A Major Growth Engine For Global Cannabis Companies {$excerpt:n} During the last year, we have highlighted the cannabis opportunity in the European Union (EU) and have stressed the importance of being levered to this market for companies, especially Canadian Licensed Producers (LPs).  One of the most significant developments…

Access to medicinal cannabis treatments in Europe {$excerpt:n} In this article, Sita Schubert, General Secretary of the European Medicinal Cannabis Association, discusses the need to get better access to medicinal cannabis treatments to patients in Europe. Currently, only around one in 300,000 patients in Europe is able to access any kind of medicinal cannabis…